Akso HealthvsMicrosoft

AHG and MSFT stock compared: price, dividend, valuation and results, from SEC filings.

AHG

Akso Health Group

$1.24

Value $896M

-3.13%
AHG's page

MSFT

Microsoft Corporation

$487.13

Value $3.62T

-2.24%
MSFT's page

Akso Health (AHG) has a market value of $896M and Microsoft (MSFT) $3.62T. Over the last year, with dividends, AHG moved -19.0% and MSFT +1.2%. Dividend yield: AHG none, MSFT 0.76%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AHG$896M

    MSFT$3.62T

    MSFT is 4,036 times AHG

  • Revenue, 12 months

    AHG$14M

    MSFT$346B

    MSFT is 25,047 times AHG

  • Net income, 12 months

    AHG-$19M

    MSFT$143B

  • Operating margin

    AHG-149.7%

    MSFT47.1%

    196.8 points apart

  • ROIC

    AHG-9.0%

    MSFT28.7%

    37.7 points apart

  • P/E

    AHG–

    MSFT25.4

  • Dividend yield

    AHG0.0%

    MSFT0.8%

    0.8 points apart

  • 5-year return

    AHG-57.7%

    MSFT+48.2%

    105.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AHG-57.7%

MSFT+48.2%

05010015020222023202420252026
Returns by period
PeriodAHGWith dividendsMSFTWith dividends
1 year since November 19, 2025-19.0%Price -19.0%+1.2%Price +0.1%
3 years since November 20, 2023+10.7%+3.5% a yearPrice +10.7%+32.2%+9.8% a yearPrice +29.2%
5 years since November 19, 2021-57.7%-15.8% a yearPrice -57.7%+48.2%+8.2% a yearPrice +42.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AHGAkso HealthMSFTMicrosoft

Valuation

AHGMSFT
Valuation
Price$1.24$487.13
Market value$896M$3.62T
Enterprise value (EV)$896M$3.66T
P/E–25.4
P/E, 5-year median–35.2
P/B5.07.7
EV/EBIT–22.4
Free cash flow yield–1.7%

Results and growth

AHGMSFT
Results and growth
Revenue, 12 months$14M$346B
Net income, 12 months-$19M$143B
Free cash flow, 12 months-$13M$60.0B
Earnings per share, 12 months$0.03$19.16
Revenue growth, year on year-6.4%17.8%
Revenue growth a year, past+51.1%over 5 years+14.6%over 5 years
EPS growth a year, past–+17.4%over 5 years

Margins and returns on capital

AHGMSFT
Margins and returns on capital
Gross margin-0.1%67.7%
Operating margin-149.7%47.1%
Net margin-135.0%41.2%
ROIC-9.0%28.7%
ROE-10.3%34.3%

Balance sheet

AHGMSFT
Balance sheet
Cash$170.6K$64.5B
Total debt$25.1K$134B
Net debt / EBITDA–0.2
Interest cover–50.6×

Dividends and buybacks

AHGMSFT
Dividends and buybacks
Dividend yield–0.8%
Dividend per share, 12 months–$3.71
Dividend growth a year, past–+10.2%over 5 years
Buyback yield–0.6%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AHG or MSFT

Didn't find what you were looking for?

Ask us
Which is bigger, Akso Health or Microsoft?

By market value, Microsoft ($3.62T) is about 4,036.4 times Akso Health ($896M), at today's prices.

How did AHG and MSFT stock do over the last 5 years?

Since November 19, 2021, AHG's price moved -57.7% and MSFT's +42.2%. With dividends: AHG -57.7% (-15.8% a year), MSFT +48.2% (+8.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, AHG or MSFT?

The dividend yield at today's price is none for Akso Health and 0.76% for Microsoft. Over the last twelve months they paid – and $3.71 per share.

Which has the higher profit margins, Akso Health or Microsoft?

Over the last twelve months, the net margin was -135.0% for Akso Health and 41.2% for Microsoft, and the operating margin -149.7% and 47.1%. Revenue was $14M and $346B.

Which is the better investment, Akso Health or Microsoft?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.